Clinical trials
Enrolling by invitation Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| China-Japan Friendship Hospital | 2 |
| AstraZeneca | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| Chinese PLA General Hospital | 1 |
| Peking Union Medical College Hospital | 1 |
| Shanghai Chest Hospital | 1 |
| Zhejiang Provincial People's Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 8 |
| Cardiovascular Diseases | 1 |
| Cerebrovascular Disorders | 1 |
| Diabetes Mellitus | 1 |
| Esophageal Squamous Cell Carcinoma | 1 |
| Glucose Intolerance | 1 |
| Margins of Excision | 1 |
| Metabolic Diseases | 1 |
| Prediabetic State | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.